Alerts will be sent to your verified email
Verify Email
KOBO
|
Kobo Biotech
|
Zyden Gentec
|
Ganga Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.35 % | 0.0 | 0.71 % |
|
5yr average Equity Multiplier
|
4.06 | 2.0 | 1.37 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.21 | 0.31 |
|
5yr Avg Net Profit Margin
|
-3.79 % | -137.59 % | 1.72 % |
|
Price to Book
|
0.0 | n/a | 0.0 |
|
P/E
|
0.0 | n/a | 89.76 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 785.76 Days | 237.0 Days |
|
Inventory Days
|
89.28 Days | 134.34 Days | 165.67 Days |
|
Days Receivable
|
0.0 | 803.05 Days | 126.89 Days |
|
Days Payable
|
147.48 Days | 421.99 Days | 119.78 Days |
|
5yr Average Interest Coverage Ratio
|
0.99 | -2.08 | 1.32 |
|
5yr Avg ROCE
|
11.79 % | -6.92 % | 3.77 % |
|
5yr Avg Operating Profit Margin
|
8.83 % | -95.87 % | 0.19 % |
|
5 yr average Debt to Equity
|
1.62 | 0.68 | 0.28 |
|
5yr CAGR Net Profit
|
n/a | -1.66 % | 31.95 % |
|
5yr Average Return on Assets
|
-0.89 % | -15.88 % | 0.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.95 % | 0.0 | 50.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.28 % | -15.8 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kobo Biotech
|
Zyden Gentec
|
Ganga Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|